Jan 16 (Reuters) - Mylan has agreed to pay $73.5 million to settle a class action lawsuit by drug wholesalers accusing the drugmaker of scheming to overcharge them for EpiPen allergy treatment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback